Liuzhou Liangmianzhen 两面针
8 significant filings since 29 May 2026: 3 on change of control, 2 on change of interest and 1 on dividend, and 2 other kinds. The latest, on 28 Aug 2026: 两面针关于高级管理人员离任暨聘任高级管理人员的公告. On 15 Jul 2026 the company said it expects net profit for the period ending 30 Jun 2026 to change by between -37.68% and +40.99% from the same period a year earlier.
自 29 May 2026 起有 8 份重大公告：change of control 3 份、change of interest 2 份、dividend 1 份，另有 2 类。最新一份（28 Aug 2026）：两面针关于高级管理人员离任暨聘任高级管理人员的公告。15 Jul 2026 公司预告截至 30 Jun 2026 的净利润较上年同期变动 -37.68% 至 40.99%。
Price History 价格走势
1 session 个交易日, Thu 24 Sep 2026 · Live one-minute prices · High 最高 ¥5.44 · Low 最低 ¥5.33 · −0.37% on the previous close of ¥5.38| Measure 指标 | This Company 本公司 | Peer Median 同业中值 | Standing 排位 | |
|---|---|---|---|---|
| Market Cap 市值 | ¥29亿 | ¥52亿 | 4th lowest of 13 · 13 家中第 4 低 | |
| Trailing P/E 市盈率 | 287.6x | 23.2x | Highest of 12 · 12 家中第 1 高 | |
| P/B 市净率 | 1.4x | 1.9x | Lowest of 13 · 13 家中第 1 低 | |
| Revenue Growth 营收增速 | -9.2% | 6.3% | Lowest of 13 · 13 家中第 1 低 | |
| Profit Growth 净利增速 | 7.9% | 7.9% | 7th highest of 13 · 13 家中第 7 高 | |
| Gross Margin 毛利率 | 16.2% | 25.5% | 2nd lowest of 13 · 13 家中第 2 低 | |
| Net Margin 净利率 | -1.0% | 6.5% | 2nd lowest of 13 · 13 家中第 2 低 | |
| Return on Equity 净资产收益率 | -0.2% | 4.1% | 2nd lowest of 13 · 13 家中第 2 低 | |
| Debt to Assets 资产负债率 | 19.4% | 33.8% | 3rd lowest of 13 · 13 家中第 3 低 | |
| Grade Score 评级得分 | 22 | 46 | Lowest of 13 · 13 家中第 1 低 |
Statement figures are for the period to 30 Jun 2026, filed by 13 of 13 peers. A rank needs 5 or more peers with a value. A company with no earnings has no P/E. 报表数据为截至 30 Jun 2026 的期间，13 家同业中 13 家已披露。排位至少需要 5 家有数据的同业；无盈利的公司没有市盈率。
| Peer 同业 | Market Cap | P/E | P/B | Revenue Growth | Net Margin | ROE | Grade |
|---|---|---|---|---|---|---|---|
| Winner Medical 稳健医疗 | ¥172亿 | 21.8x | 1.5x | 3.6% | 9.9% | 4.4% | D |
| Chongqing Baiya Sanitary Products 百亚股份 | ¥97亿 | 48.9x | 6.8x | 6.0% | 9.6% | 11.8% | C |
| C&S Paper 中顺洁柔 | ¥89亿 | 22.5x | 1.6x | 1.8% | 5.2% | 4.1% | D |
| Runben Biotechnology 润本股份 | ¥82亿 | 23.2x | 3.5x | 17.7% | 21.4% | 9.7% | B |
| Tongling Jieya Biologic 洁雅股份 | ¥58亿 | 67.4x | 3.0x | 35.1% | 9.9% | 2.2% | C |
| Haoyue Care 豪悦护理 | ¥53亿 | 22.5x | 1.6x | 11.4% | 7.8% | 4.5% | C |
| Dencare Oral Care 登康口腔 | ¥52亿 | 26.5x | 3.5x | 14.2% | 10.5% | 6.5% | C |
| Xiamen Yanjan New Material 延江股份 | ¥35亿 | 58.5x | 2.6x | 5.8% | 5.1% | 3.4% | D |
| Tianjin Yiyi Hygiene Products 依依股份 | ¥31亿 | 23.1x | 1.7x | -4.9% | 6.5% | 2.9% | D |
| Liuzhou Liangmianzhen 两面针 | ¥29亿 | 287.6x | 1.4x | -9.2% | -1.0% | -0.2% | E |
| Perfect 倍加洁 | ¥26亿 | 21.6x | 2.3x | 22.2% | 6.4% | 4.3% | D |
| Hangzhou COCO Healthcare Products 可靠股份 | ¥25亿 | — | 1.9x | 6.3% | -1.1% | -0.6% | E |
| Nbond 诺邦股份 | ¥23亿 | 21.6x | 1.6x | 15.9% | 3.8% | 3.6% | D |
Peers are listed by market cap, with this company highlighted. 同业按市值排列，本公司高亮显示。